Differentiation is a highly controlled process essential for embryonic and adult development. Moreover, disruption of proper differentiation is often associated with human diseases, including cancer. We analyzed the involvement of the tumor-suppressor Lats2 in mouse embryonic stem cell (mESC) pluripotency and differentiation, and report that mESCs lacking Lats2 are unable to sustain stemness and are not able to initiate and coordinate developmental transcriptional programs. Lats2 À / À mESCs retain bivalent 'poised' chromatin marks on developmental genes and exhibit germ layer ambiguity both in vitro and in vivo. Importantly, in coordinating proper germ layer specification, Lats2 engages in a feedback loop with another tumor suppressor, p53.
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Embryonic stem cells (ESCs) are unique in that they self-renew and harbor the potential to differentiate into all adult cell types (characteristics of 'stemness'). A delicately balanced network of transcription factors is crucial for both ESC immortality and pluripotency. Highlighting the importance of transcription is the discovery that overexpression of a distinct set of transcription factors suffices to reprogram differentiated adult cells into induced pluripotent stem cells (iPSCs). 1 It is noteworthy that disabling the tumor-suppressor p53 improves the efficiency of iPSC production. [2] [3] [4] [5] [6] Deregulation of genes important for maintaining stemness is also invariably implicated in cancer. 7 In fact, oncogenic transformation often hijacks and distorts developmental transcriptional wiring. Following hand in hand with transcriptional alterations, formation of bivalent chromatin domains characteristic of stem cells facilitates tumorigenesis. 8 Notably, undifferentiated tumors bearing transcriptional signatures indicative of stemness generally predict worse prognosis. 9 In a complementary manner, tumor suppressors often promote differentiation. 10 The Hippo cascade is a highly conserved tumor-suppressor pathway, 11 whose inactivation can result in dramatic overgrowth (in flies) or tumors (in mammals). 12 The Ser/Thr kinases Lats2 and Lats1 act as central mediators of the Hippo activity by negatively regulating the pathway's downstream effectors Yap and its paralog Taz. Phosphorylation of Yap by the Lats kinases expels Yap from the nucleus and targets it for proteasomal degradation. 13 Yap function affects numerous tumor-associated attributes, such as cell contact inhibition, mechanosensing and proliferation.
14 During development, Yap modulates stem cell behavior 15 and preimplantation cell lineage. 16 To complicate matters, there is mounting evidence for Lats-independent Yap functions. 14, 17 Moreover, Lats2 has a spectrum of functions that extend beyond Yap regulation, including maintenance of genome stability, induction of apoptosis, cell cycle and tetraploidy checkpoint control and inhibition of cell migration. 18 One striking example of this is Lats2 interaction with components of the p53 pathway. Lats2 expression is positively regulated by p53, 19 and the Lats2 gene is a direct transcriptional target of p53. 20 Furthermore, Lats2 binds and inhibits the negative regulator of p53, Mdm2, whereas it promotes the nuclear localization and transcriptional functionality of the proapoptotic p53 coactivator ASPP1. 20, 21 These interactions serve to augment the p53 transcriptional response, defining a p53-Lats2 positive feedback loop.
We now report that Lats2 À / À ESCs are compromised both in their ability to maintain pluripotency and their ability to respond effectively to differentiation triggers. The differentiation defect is associated with a failure of Lats2-deficient ESCs to resolve bivalent chromatin modifications in response to differentiation signals. Inability of Lats2 À / À ESCs to sustain a coordinated epigenetic program hampers transcriptional induction of differentiation-specific genes, resulting in unbalanced differentiation into the three germ layers both in vitro and in vivo. Moreover, during normal ESC differentiation, Lats2 expression is selectively induced in a p53-dependent manner. We propose that during the differentiation process, Lats2 is recruited to the p53 pathway to coordinate proper transcriptional reprogramming.
Results
Lats2 À / À ESCs are less pluripotent and differentiate ineffectively. Lats2 À / À mice are embryonic lethal, death occurring at BE10.5-E12.5. 22, 23 To investigate the role of Lats2 in early development, we generated several independent Lats2 À / À ESC clones, as well as matched wild-type (WT) control clones, by intercrossing C57BL/6 mice heterozygous for a Lats2-null allele (Lats2 þ / À ). Unless otherwise indicated, all experiments were performed with three independent WT clones and three independent Lats2 À / À clones.
Colonies of WT and Lats2 À / À ESCs were indistinguishable morphologically ( Figure 1a) . However, significant differences between the two genotypes became apparent when we compared the activity of alkaline phosphatase (AP). Staining intensity of AP activity, a biomarker of undifferentiated stem cells, was quantified in a high-throughput manner (Supplementary Figure S1 ). As seen in Figure 1b (left panel), the average AP intensity of Lats2 À / À ESC colonies was significantly lower than that of WT ESC colonies. Moreover, unlike the case for WT ESCs, only a rather small fraction of Lats2 À / À ESCs could give rise successfully to AP-positive colonies (Figure 1b , right panel), implying a defect in self-renewal capacity. Together, these results indicate that Lats2 is required for sustaining full 'stemness' and self-renewal potential in the absence of differentiation signals.
Lack of Lats2 has been associated with a variety of chromosome instability phenotypes. 20, 22, 23 We therefore asked whether, in addition to pluripotency defects, Lats2 À / À ESCs might be susceptible to genomic anomalies. To that end, WT and Lats2 À / À ESC clones were propagated to high passage number (passage 420). FACS analysis was performed to determine ploidy and replication kinetics. WT ESC clones retained a uniform, diploid cell cycle distribution; in contrast, Lats2 À / À clones acquired aberrant, excessive DNA content (Figure 1c and Supplementary Figure S2A) ; in addition, they displayed a slightly higher fraction of cells in the S phase (Supplementary Figure S2B) . Fluorescent spectral karyotyping (SKY) analysis revealed that although late-passage WT ESCs maintained normal chromosome numbers, Lats2 À / À ESCs exhibited near-tetraploid genomes, with the number of copies of different individual chromosomes varying from 2 to 5 ( Figure 1d and Supplementary Figure S2D ). In view of the tendency of Lats2 À / À clones to develop aneuploidy, we performed all subsequent experiments on early passage cultures (passage o12), when both genotypes still retained a normal karyotype. Lats2 À / À ESCs and Lats2 À / À embryos execute differentiation programs aberrantly and inefficiently. Embryoid body (EB) formation is often used as a means to initiate spontaneous differentiation of ESCs to the three germ layers. EBs are three-dimensional multicellular spheroids that mimic patterning in the early developing embryo. 24 At 5 days following induction of EB formation, a marked difference in size was observed between WT and Lats2 À / À EBs (Figure 2a , left panels); Lats2 À / À EBs were approximately twice the diameter of WT EBs and appeared more dense than WT EBs. In most WT EBs, differentiation of exterior cells to primitive endoderm and the resultant ring of extracellular matrix (ECM) could be visualized by phase contrast microscopy. In contrast, most Lats2 À / À EBs did not exhibit definitive basement membrane delineation. By 12 days of EB development, both WT and Lats2 À / À EBs reached maximum size. However, whereas WT EBs retained a uniform distribution of mass, Lats2 À / À EBs exhibited a very irregular internal bulk. Histological sections of EBs at day 18 revealed that WT EBs displayed the expected architectural features: a thin, even layer of endoderm external to a regular basement membrane. In contrast, Lats2 À / À EBs displayed an aberrant architecture with thick, uneven endoderm and a discontinuous, irregular basement membrane (Figure 2a , right panels). To further characterize the WT and Lats2 À / À EBs, we performed immunofluorescent staining of Foxa2, an endoderm marker. Whereas WT EBs consistently exhibited a clearly delineated endodermal layer (Figure 2b ), the endoderm of individual Lats2 À / À EBs revealed either massive hyperproliferation or hypoproliferation (Figure 2b , right and middle panels, respectively). Hence, Lats2 À / À EBs develop irregularly, with abnormal architecture and aberrant germ layer distribution and size.
Oct4 is a key component of the ESC transcriptional circuitry, and is essential for maintenance of the undifferentiated, pluripotent state. 25 Induction of differentiation, for example by retinoic acid (RA), elicits rapid shutoff of Oct4 expression. Indeed, within 3 days of RA treatment, Oct4 protein and RNA became barely detectable in WT ESCs (Figures 3a and b, respectively). In contrast, Lats2 À / À ESCs displayed a dual defect in regulation of Oct4 expression. On one hand, basal Oct4 levels in the undifferentiated state were almost twofold lower in Lats2 À / À ESCs than in WT ESCs. On the other hand, Lats2 À / À ESCs failed to efficiently shut off Oct4 expression in response to differentiation signals, and retained detectable Oct4 even after 6 days of RA treatment (RA-D6). Similarly, the expression of other pluripotency markers such as Esrrb, Klf4 and Rex1 was also significantly lower in Lats2 À / À ESCs than in WT ESCs ( Figure 3c ). In addition, similar to Oct4, expression of Klf4 and Rex1 was retained at elevated levels in RA-treated Lats2 À / À ESCs. Notably, the impaired ability of Lats2 À / À ESCs to maintain basal expression of pluripotency genes was also apparent when the different ESC strains were propagated in 2i medium that retains ESCs in a more 'naive' state (Supplementary Figure S1B) . A complex network of transcription and epigenetic factors maintain ESCs in a pluripotent state by repressing genes required for germ layer specification. Once differentiation commences, such genes are activated in a lineage-specific manner, thus driving induction of germ layer-specific transcription programs and cell-fate determination. 26 As expected, RA treatment of WT ESCs for 6 days led to efficient induction of genes representative of all three germ layers: 27 Pax6 (ectoderm), Flk1 (mesoderm) and Gata6 (endoderm) (Figure 3d ). However, induction of these genes was severely compromised in Lats2 À / À ESCs. Hence, Lats2 deficiency leads to a generalized defect in differentiation into all three germ layer fates.
To exclude the possibility that the differentiation defect of Lats2-deficient ESCs was specific to RA treatment, we subjected cells to a hepatocyte differentiation protocol. WT ESCs rapidly decreased expression of Sox2 mRNA and subsequently reduced Oct4 expression (Figure 4a ). This sequential decrease in Sox2 followed by Oct4 is characteristic of cells undergoing mesendodermal differentiation. 26 In contrast, despite low basal Sox2 mRNA, no further reduction was observed in Lats2 À / À ESCs, even after 26 days. Repression of Oct4 at day 26 was also partly compromised in Lats2 À / À ESCs. Similarly, induction of progenitor and mature hepatocyte genes was impaired in the Lats2 À / À ESCs. Notably, although the hepatoblast transcription factor HNF4a was partly upregulated in Lats2 À / À ESCs (Figure 4b) , albumin, indicative of mature functional hepatocytes, was not induced at all and remained at basal predifferentiation levels. The inability of Lats2 À / À ESCs to complete differentiation into mature hepatocytes was validated by albumin immunostaining (Figure 4c ). Albumin-positive WT cells clustered in groups adjacent to regions of spontaneously differentiated beating cardiomyocytes, a phenomenon previously reported to occur during in vitro hepatocyte differentiation. 28, 29 In contrast, Lats2 À / À cells displayed only background albumin staining (Figure 4c) , and no beating cells were observed. Hence, Lats2 is necessary for the full 
Teratomas are benign tumors characterized by an intrinsic ability to yield all three germ layers. Indeed, when injected into nude mice, WT ESCs generated teratomas harboring differentiated cells of all three lineages (Figure 5a ). In contrast, although Lats2 À / À ESCs gave rise to teratomas of comparable size, these teratomas consistently tended to differentiate into only one or two germ layers per injection, with no preference for any particular germ layer specification. Germ layer inclination was unpredictable, as even replicate injections of an identical clone generated teratomas with different lineage imbalances (Figure 5a ). Hence, Lats2 À / À ESCs are not inherently biased toward a particular differentiation scheme, but rather have a global defect in negotiating complex differentiation programs.
To test this notion in a more physiological setting, we turned to in vivo embryogenesis. As mentioned above, Lats2 À / À embryos die at day E10.5-E12.5 because of neuronal 22 or cardiac 23 differentiation defects. We therefore compared gene expression patterns between WT and Lats2 À / À embryos obtained at day E8.5, before any phenotypic difference was observed. 22, 23 Analysis of RNA isolated from whole embryos revealed that at this stage, when embryonic germ layer differentiation commences, Lats2 À / À embryos retained a nearly twofold excess of Oct4 expression (Figure 5b ). It is also noteworthy that compared with littermate WT embryos, Lats2 À / À embryos exhibited a pronounced imbalance of ectoderm/endoderm differentiation (Figure 5b ). These observations are consistent with our in vitro data and support the notion that Lats2 is essential for proper coordination of balanced differentiation into the different lineages.
Lats2 À / À ESCs retain bivalent chromatin markers. Epigenetic markings play critical roles in regulating the expression of developmental genes. 30 In ESCs, many key developmental genes are associated with bivalent chromatin, decorated simultaneously with both repressive histone H3 Lys27 trimethylation (H3K27me3) and activating histone H3 Lys4 trimethylation (H3K4 me3) marks. 31 To (Figure 6a , left panel): both cell types presented high levels of H3K4me3 and low levels of H3K27me3 adjacent to the transcription start sites (TSS) of the pluripotency genes Oct4 and Nanog. Moreover, in both undifferentiated WT and Lats2 À / À ESCs, activating and repressive histone marks were simultaneously present near the TSS of the genes encoding the ectodermal transcription factors Pax6 and Sox21, indicative of their bivalent state. Hence, in the basal state we did not detect substantial differences in epigenetic landscape between the two cell types. However, within 4 days of RA treatment, marked differences became apparent (Figure 6a, right panel) . As expected, WT ESCs significantly diminished H3K4me3 and augmented H3K27me3 near the TSS of Oct4 and Nanog. In addition, the bivalency at the Pax6 and Sox21 loci was resolved into high H3K4me3 and low H3K27me3. In contrast, Lats2 À / À ESCs exhibited marked epigenetic defects upon exposure to differentiation signals. Specifically, Lats2 À / À ESCs sustained relatively high levels of H3K4me3 and low levels of H3K27me3 on pluripotency genes. Importantly, Lats2 À / À ESCs retained bivalency on Pax6 and Sox21, indicating that they remained frozen in their poised state, unable to either extinguish pluripotency or commit to a specific differentiation program.
Lats2 expression is induced during differentiation in a p53-dependent manner. Given the impact of Lats2 on embryogenesis and embryonic SC biology, we next explored the regulation of Lats2 gene expression in these cells. As shown in Figure 6b , Lats2 mRNA was markedly induced upon treatment of WT ESCs with RA. Lats2 transcription is positively regulated by p53 through direct binding of p53 to the Lats2 promoter. 20 We therefore utilized p53 À / À ESCs to investigate the p53 dependence of Lats2 induction. Remarkably, whereas basal Lats2 mRNA levels were not significantly affected by p53 depletion, RA-induced Lats2 upregulation was strongly compromised in p53 À / À ESCs (Figure 6b ). Both Lats2 and Lats1 act in the Hippo pathway; however, RA elicited only a mild change in Lats1 expression that was unaffected by depletion of either p53 or Lats2 (Supplementary Figure S3) . Hence, p53 specifically transactivates Lats2 during ESC differentiation.
In addition to Lats2, the canonical p53 targets p21 and PUMA were also induced by RA treatment in WT ESCs (Figure 6c) , indicative of generalized p53 activation during ESC differentiation. Interestingly, exposure of undifferentiated ESCs to the p53-activating drug Nutlin-3 strongly upregulated p21 and PUMA (Figure 6c ) but not Lats2 (Figure 6d ). In contrast, in differentiating cells (RA-D4), Lats2 was prominently further upregulated upon p53 activation by Nutlin-3 (Figure 6d ), whereas p21 and PUMA were not (Figure 6c ). This implies a distinct mode of regulation of the Lats2 gene during ESC differentiation. Specifically, it suggests that in undifferentiated cells, Lats2 may be actively prevented from responding to p53, becoming 'unlocked' only in response to differentiation signals.
Regulation of Yap and p53 transcriptional targets by differentiation and Lats2 deletion. Next, we wished to explore the signaling pathways affected downstream to Lats2 during differentiation. As mentioned previously, Lats2 has well-documented functions in the Hippo pathway, upstream to Yap and Taz, 32 and also affects the p53 pathway through inhibition of Mdm2. 20 As predicted from the canonical Hippo signaling, Lats2 À / À ESCs displayed augmented, although mild, basal expression levels of the Yap targets CTGF, Cyr61 and Birc5 33 ( Figure 7a , compare NT Lats2 À / À with NT WT), confirming that Lats2 can curtail Yap activity in this system. Although RA treatment caused a marked upregulation of CTGF mRNA, other Yap targets were not consistently induced during differentiation (Figure 7a) . Together, these observations suggest that Yap transcriptional activity probably does not play a substantial role in the RA response of these cells.
To further evaluate the involvement of Yap in ESC differentiation, we employed the Yap inhibitor Verteporfin (VP). 34 As expected, VP strongly decreased CTGF expression in both WT and Lats2 À / À ESCs (Figure 7b) . Importantly, VP did not rescue the differentiation defect of Lats2 À / À ESCs, as assessed by its effect on Oct4 expression (Figure 7c) . Similarly, the failure of Lats2 À / À ESCs to upregulate differentiation-specific genes, such as Gata6, was also not effectively relieved by VP treatment. The inability of VP to restore proper differentiation capacity to Lats2 À / À ESCs substantiates the assertion that Yap hyperactivation is probably not the main driver of the differentiation defect of these cells.
Lats2 is required for optimal p53 activation in response to a variety of stresses. 35 We therefore hypothesized that Lats2 might not only be transcriptionally regulated by p53 in ESCs (Figure 6b ), but might also facilitate p53 activation during differentiation of these cells. Treatment with RA led to a gradual prominent increase in p53 protein levels (Figure 8a , left panels), in line with our observation that p53 target genes were upregulated under those conditions (Figure 6c) . Importantly, ESCs lacking Lats2 were less capable of fully activating p53 during differentiation; this was apparent in p53 protein levels (Figure 8a , right panels) as well as in p53 target gene transcriptional activation, as exemplified by p21 and PUMA (Figures 8b and c) . In that regard, Lats2 À / À ESCs mimicked to some extent the defect of p53-null ESCs. Our data support a scenario in which Lats2 operates via p53-mediated mechanisms during differentiation, and compromised p53 activation at least partially contributes to the differentiation defect of Lats2 À / À ESCs.
Discussion
In this study, we report that ESCs lacking Lats2 are both less able to sustain pluripotency and less capable of responding efficiently to differentiation signals. Thus, when exposed to differentiation triggers, Lats2 À / À ESCs retain bivalent 'poised' chromatin marks on developmental genes, and stem cell-like epigenetic marks on pluripotency genes. This epigenetic ambiguity may underlie the inability of Lats2 À / À ESCs to execute efficiently the transcriptional programs required for proper differentiation. As bivalency presumably maintains a permissive chromatin structure, simultaneously poised for differentiation-specific gene expression while preserving pluripotency, we propose that Lats2-dependent resolution of bivalency and maintenance of epigenetic order might be critical to avoid 'confused' developmental messages. Indeed, as reported recently, transient reduction of Lats1 and Lats2 in early preimplantation embryos traps cells in a conflicting trophectoderm-inner cell mass (TE-ICM) developmental impasse. 16, 36 We now show that lack of Lats2 causes cells to express contradictory lineagespecific transcripts also subsequent to the first TE-ICM cell lineage specification; in ESCs originating from the ICM as well as in embryos at later developmental stages (E8.5) (Figure 5b) . In all cases, absence of Lats2 gives rise to discordant developmental processes.
Upon differentiation, bivalent H3K4me3/H3K27me3 marks are resolved to monovalency in tune with establishment of lineage-specific gene expression programs. 37 Interestingly, ESCs deficient for H3K27 methylation display inappropriate expression of conflicting lineage-specific genes, 38 reminiscent of the defect we observe in Lats2 À / À ESCs. It is noteworthy that some differentiated cells such as multipotent neural and hematopoietic stem cells and embryonic fibroblasts also possess bivalent marks, 38, 39 suggesting that bivalency might better represent plasticity, rather than pluripotency. Moreover, it was recently demonstrated that precursor cancer SCs are plastic cell populations that can transition from epithelial to mesenchymal identity by regulating bivalent/monovalent marks on developmental genes. 40, 41 The related aspects of the Lats2 À / À phenotype may not be coincidental, as one of the hallmarks of defective Hippo signaling is enhanced EMT. 42 Although Lats2 is best recognized for its role as a negative regulator of Yap in the Hippo pathway, our data strongly suggest that it is not solely in this capacity that Lats2 maintains the proper chromatin landscape and transcriptional performance of ESCs. Yap overexpression has been reported to augment stemness. 15, 43 More recently, it has been suggested that Yap may actually play a positive role in hepatocyte differentiation. 44 In that regard, the phenotypes described here for Lats2 À / À ESCs (failure to maintain stemness and inability to differentiate into mature hepatocytes) are contrary to those observed in response to Yap hyperactivation. Importantly, inhibition of Yap activity failed to rescue the transcriptional defect of Lats2 À / À ESCs (Figure 7c) . Furthermore, if disabling Yap were the primary role of Lats2 in differentiation and development, then one might expect Lats1 and Lats2 to behave similarly. However, this does not appear to be the case. Thus, although Lats2 is essential for embryonic development, 45, 46 Lats1 knockout mice are viable. 47 Moreover, as shown here (Figure 6a ), whereas Lats2 expression is strongly induced during differentiation, Lats1 expression is not. Lastly, we show that Lats1 expression in differentiating ESCs is affected neither by p53 levels nor p53 activity, both of which strongly affect ESC differentiation. [48] [49] [50] Hence, our findings reflect a unique role for Lats2 in the delicate balance of signals required for proper differentiation.
Intriguingly, Yap and Taz appear to possess divergent roles in mouse as compared with human cells. Whereas Yap can regulate mouse ESC self-renewal 51 and increase the efficiency of mouse iPSC generation, 52 it does not appear to have such role in human ESCs 53 or in human iPSC generation. 54 The opposite holds for Taz: although Taz mediates human ESC renewal 55 and iPSC reprogramming, 54 it does not appear to have a similar role in mouse ESCs. 55 The reason for this intriguing apparent switch of tasks remains unclear. Yet, despite the reportedly more prevalent contribution of Yap in the mouse setting, lack of Yap inhibition does not seem to underlie the defects that we observe in Lats2 À / À ESCs.
We propose that during differentiation, Lats2 functions primarily via p53-mediated mechanisms. p53 is a major driving force for ESC differentiation. ESCs lacking p53 are less prone to spontaneous differentiation 56 but also more impervious to RA-driven differentiation. 57 Furthermore, p53 À / À progenitor cells have an increased tendency toward aneuploidy, particularly at higher passages. 58 The similarities between the impact of p53 loss and Lats2 loss on ESCs, along with the mutual cross-regulation of these two tumor suppressors, strengthen the conjecture that Lats2 and p53 work hand in hand to oversee proper differentiation.
Additional mechanisms for Lats2 function in ESC differentiation are plausible, and are not mutually exclusive with the proposed Lats2-p53 axis. Indeed, two very recent studies demonstrate critical roles for Lats proteins and the Hippo signaling in coordinating crosstalk with other pathways during differentiation of mammalian adipocytes 59 and in fly retina. 60 In addition, Lats2 might phosphorylate a subset of epigenetic machinery proteins, or even directly bind and phosphorylate The role of Lats2 in differentiation Y Aylon et al chromatin itself. Either way, the end result is that Lats2-deficient ESCs remain suspended in differentiation limbo, unable to retain pluripotency or to fully commit to mature cell types. In sum, the Hippo and p53 tumor-suppressor pathways have well-documented roles in controlling proliferation, survival and genomic integrity. Recent evidence, including the present study, also implies a central role for those tumor suppressors in the regulation of stem and progenitor cells, and loss of their function in such cells may be a key event in the initiation of many cancers. We propose that Lats2, a constituent of both Hippo and p53 pathways, plays a particularly critical role in regulating ESC pluripotency and differentiation.
Materials and Methods
Isolation and culture of mESCs. C57BL/6 Lats2 þ / À (5821, Jackson Laboratory, Mt Desert Is., ME, USA) mice were time mated. E2.5 morulas were isolated from the uteri of female mice and allowed to attach to irradiated MEF feeder layers. Subsequently, 2i medium (media recipes listed in Supplementary Materials and Methods) was changed daily. After colonies were established, ESCs were acclimated and maintained in mES medium. For differentiation experiments, feeders were depleted by 30-45 min of incubation on 0.1% gelatin, followed by gentle aspiration of purified ESCs. For RA-induced differentiation, feeder-depleted cells were seeded on gelatin and transferred to differentiation medium containing 1 mM RA. RA was replenished daily. EBs were generated using the hanging drop method (660 feeder-depleted cells/20 ml) on the lid of a tissue culture dish and then transferred to plastic Petri dishes in differentiation media. For teratoma formation in mice, 1.5 Â 10 6 cells were resuspended in PBS with 30% Matrigel. Hind quarters of 8-week-old CD1 nude mice (Harlan Labs, Indianapolis, IN, USA) were injected subcutaneously. Mice were killed 4 weeks after injection. All mouse procedures were performed under approval of the Institutional Animal Care and Use Committee (IACUC no. 06131209).
Immunofluorescence. EBs were fixed in 4% paraformaldehyde (PFA) for 30 min at RT and resuspended in 4% agarose. Agarose plugs were fixed for another 2 h in 4% PFA and embedded in paraffin. Slides were then stained for H&E or subjected to IHC, using standard procedures. Differentiating cells were grown on 12 mm coverslips and fixed with ice-cold methanol for 20 min at 41C. Samples were then incubated for 1 h with primary antibodies (Foxa2, ab40874 or albumin, ab106582; Abcam, Cambridge, UK), washed and then incubated with secondary antibody and DAPI (5 mg/ml final) for 40 min in the dark.
Additional Materials and Methods are detailed in Supplementary Materials and Methods.
